Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in adjuvant breast cancer chemotherapy
NCT03205033Phase 2Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jan 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of melatonin in circadian rhythm sleep-wake disorder (CRSWD), sponsored by Hospital de Clínicas de Porto Alegre. Started Jan 2016; status: completed.
02
Drugs
melatonin
03
Conditions
circadian rhythm sleep-wake disorder (CRSWD)
Beyond the preview
Go deeper on NCT03205033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205033.